Abhishek Bose
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Abhishek Bose.
Journal of Cardiovascular Electrophysiology | 2014
Abhishek Bose; Jagdesh Kandala; Gaurav A. Upadhyay; Lindsay Riedl; Imad Ahmado; Ram Padmanabhan; Henry Gewirtz; Lawrence J. Mulligan; Jagmeet P. Singh
Cardiac resynchronization therapy (CRT) recipients with ischemic cardiomyopathy (ICM) have scar segments that may limit ventricular resynchronization and clinical response. The impact of myocardial viability at the left ventricular (LV) pacing site on CRT response is poorly elucidated.
Heart Rhythm | 2015
Łukasz Januszkiewicz; Eszter M. Vegh; Rasmus Borgquist; Abhishek Bose; Ajay K. Sharma; Theofanie Mela; Jagmeet P. Singh; Kimberly A. Parks
BACKGROUND Prolongation of the baseline ECG PR interval is frequently encountered among cardiac resynchronization therapy (CRT) recipients. There are conflicting data regarding the association of a prolonged PR interval with long-term clinical outcome in this patient group. OBJECTIVE The purpose of this study was to compare clinical outcomes and response to CRT in patients with normal (<200 ms) vs prolonged (≥200 ms) baseline PR interval. METHODS In this study, 283 patients (normal PR interval: n = 158; prolonged PR interval: n = 125) with documented baseline intrinsic PR interval were followed for 3 years after CRT implantation. The study population consisted of 24.7% women (mean age 66 ± 13 years, left ventricular ejection fraction 24% ± 7%). RESULTS A Cox proportional hazard model identified baseline PR interval as a predictor of the composite end-point (all-cause mortality, heart failure hospitalization, left ventricular assist device implantation, and heart transplantation) in univariate analysis (hazard ratio [HR] 1.49, 95% confidence interval [CI] 1.02-2.17, P = .04) but not in multivariate analysis. It also predicted heart failure hospitalization in univariate (HR 1.6, 95% CI 1.1-2.4, P = .02) and multivariate analysis (HR 1.6, 95% CI 1.0-2.3, P = .03). A prolonged PR interval was associated with lower probability of reverse remodeling defined as ≥10% improvement in ejection fraction (64% vs 77%, P = .057), especially in patients with non-left bundle branch block ECG morphology (41% vs 68%, P = .03). CONCLUSION Among patients with CRT, a prolonged baseline PR interval is an independent predictor of worse prognosis and lower probability of reverse remodeling, especially for patients with non-left bundle branch block morphology on ECG.
Journal of Cardiovascular Electrophysiology | 2013
Jagdesh Kandala; Gaurav A. Upadhyay; Robert K. Altman; Abhishek Bose; E. Kevin Heist; Theofanie Mela; Jagmeet P. Singh
Electrical Delay in Apically Positioned LV Leads. Introduction: In recent studies, an anatomical apical left ventricular (LV) lead pacing location has been associated with deleterious outcome after cardiac resynchronization therapy (CRT). The differential impact of the LV lead electrical location in these patients remains unknown.
Journal of Interventional Cardiac Electrophysiology | 2015
Abhishek Bose; Quynh A. Truong; Jagmeet P. Singh
Circulating biomarkers related to inflammation, neurohormones, myocardial stress, and necrosis have been associated with commonly encountered arrhythmic disorders such as atrial fibrillation (AF) and more malignant processes including ventricular arrhythmias (VA) and sudden cardiac death (SCD). Both direct and indirect biomarkers implicated in the heart failure cascade have potential prognostic value in patients undergoing cardiac resynchronization therapy (CRT). This review will focus on the role of biomarkers in AF, history of SCD, and CRT with an emphasis to improve clinical risk assessment for arrhythmias and patient selection for device therapy. Notably, information obtained from biomarkers may supplement traditional diagnostic and imaging techniques, thus providing an additional benefit in the management of patients.
Journal of Cardiovascular Electrophysiology | 2014
Abhishek Bose; Gaurav A. Upadhyay; Jagdesh Kandala; Edwin Kevin Heist; Theofanie Mela; Kimberly A. Parks; Jagmeet P. Singh
Cardiac valve surgery (CVS) has been implicated as a potential barrier to optimal response after cardiac resynchronization therapy (CRT) though prospective data regarding outcome remains limited. We sought to determine CRT response in patients with a prior history of CVS.
Journal of the American College of Cardiology | 2012
Abhishek Bose; Jagdesh Kandala; Gaurav A. Upadhyay; Imad Ahmado; Robert K. Altman; Lindsay Riedl; Lawrence J. Mulligan; Jagmeet P. Singh
Although scar has been associated with poor outcome after CRT, the impact of coronary artery disease (CAD) severity or ischemia on CRT response remains uncertain. A prospective cohort of CRT patients with ischemic cardiomyopathy was evaluated for ischemia and scar with nuclear perfusion imaging.
Circulation | 2016
Abhishek Bose; Wesley T. O’Neal; Aleena Bennett; Suzanne E. Judd; Waqas Qureshi; Xuemei Sui; Virginia J. Howard; George Howard; Elsayed Z. Soliman
/data/revues/00029149/unassign/S0002914914009631/ | 2014
Ajay K. Sharma; Eszter M. Vegh; Jagdesh Kandala; Lukasz Januszkiewicz; Abhishek Bose; Alexandra Miller; Kimberly A. Parks; E. Kevin Heist; Jagmeet P. Singh
Circulation-cardiovascular Quality and Outcomes | 2013
Abhishek Bose; Jagdesh Kandala; Jagmeet P. Singh
Circulation | 2013
Abhishek Bose; Jagdesh Kandala; Daniel J. Friedman; Alefiyah Rajabali; Eszter M. Vegh; E. Kevin Heist; Theofanie Mela; Jagmeet P. Singh